All stories
Latest news
Every story from the Euros Room, newest first.
€
Palantir's Alex Karp says AI's biggest names may never IPO, the play is telling Washington 'nationalize us, please'
€
Trump, Xi seek trade stability and deals, but AI, tariffs and Iran loom large. What to watch
Trump, facing low approval on the economy ahead of the midterm election, has an added incentive to emerge from the summit with Chi…
€
Apollo (APO) Nears a 16% Stake in the Yankees. Why Private Equity Wants a Piece of Baseball
€
Forget JEPI: Invesco’s Equal-Weight Income Fund Is Beating It by 6+ Points With Lower Fees
€
The World's First Autocallable ETF
€
Village Farms Eyes Global Cannabis Growth With EU GMP Edge and Net Cash
€
Micron Stock Is Back Above $1,000. Is a Stock Split Coming?
€
A Record ETF Year Takes Shape as Inflows Near $1.5 Trillion
€
Faraday Future (FFAI) Bets on Robotics Beyond EVs, but the Revenue Opportunity Still Needs Proof
€
How to Play CrowdStrike Stock at All-Time Highs
€
AMD Stock Alert: Advanced Micro Devices Joins the Trillion-Dollar Club
€
Stocks Settle Sharply Higher as Crude Prices Plunge and Chipmakers Soar
€
Oura seeks to raise up to $2.2B in IPO
€
X Sues Two Bitcoin Influencers Over Bot Army That Milked Creator Payouts
A lawsuit accuses UK users of running six coordinated accounts to pull at least $278,000 from X's now-defunct Creator Revenue Shar…
€
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
€
AXT Inc. (AXTI) Climbs 16% on S&P 600 Addition
€
Jefferies Just Upgraded Arhaus Stock. Here's Why.
€
How Far Could Zoom Communications Stock Fall In A Real Market Shock?
€
Retailer Revolve announces partnership with Donatella Versace
REVOLVE's partnership with Donatella Versace is the retailer's latest bid to create for young consumers.
€
Diesel Supply Down 8%: What Trucking Faces Next
€
Jim Cramer on Credo (CRDO): “I Think You Can Buy the Stock”
€
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
€
Is MercadoLibre Stock As Cheap As Its Cash Says?
€